<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>CLINICAL PHARMACOLOGY OF ANTIVIRAL DRUGS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Ergashev Asilbek Qudrat</mods:namePart><mods:namePart type="family">oʻgʻli</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Abdunazarov Azimjon Alisher</mods:namePart><mods:namePart type="family">oʻgʻli</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Chariev Muzaffar</mods:namePart><mods:namePart type="family">Yuldashevich</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This article discusses the clinical pharmacology, mechanism of action, time of action, types and composition of antiviral drugs. The article introduces new antiviral drugs being developed in the pharmaceutical industry, their pharmacotherapeutic groups, international non-patented names, and the country of manufacture. Nowadays, the need for antiviral drugs is increasing. Because it is the time when seasonal viral diseases and allergies are on the rise and immunity decreases to a certain extent. Therefore, we will get acquainted with the new anti-viral drugs included in the State Register.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-01-20</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>